US Anti-Fungal Market Growing Trade Among Emerging Economies Opening New Opportunities (2023-2028)

The US Anti-Fungal Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global US Anti-Fungal market. This report explores all the key factors affecting the growth of the global US Anti-Fungal market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141792/

Report Description of the US Anti-Fungal Market Analysis

Research Scope and Assumption

The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
Inflation has not been accounted for in order to estimate and forecast the market
Numbers may not add up due to rounding off

Reason to buy the report:

Facilitate decision-making based on strong current and forecast data for US Anti-Fungal Market Analysis
Develop strategies based on the latest regulatory framework
Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the US Anti-Fungal Market Analysis
Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
To strategically profile key players and comprehensively analyze their market shares and core competencies
We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

US Anti-Fungal Market Analysis Executive Summary

Antifungal drugs are commonly used to cure fungal infections due to unclean, unhygienic, and damp environments. Invasion of epithelial tissue by microscopic organisms leads to fungal infections. Systemic fungal infections are caused due to indigestion or inhalation of spores, leading to fungal pneumonia, and diseases like candidiasis, meningitis, mucormycosis, etc., are caused by opportunistic fungus. Although the majority of fungal infections and diseases are commonly non-lethal, they are very uncomfortable to the host, and their common occurrence is responsible for the rising antifungal drugs market. Antifungal drugs work via various mechanisms such as inhibiting cell wall formation, cell membrane disruption, and cell division.

Market Size and Key Findings

The US Anti-Fungal Market Analysis size stood at around USD 5.15 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 3.7% during the forecast period.

The Antifungal Drugs Market size in North America is estimated at USD 5.15 billion in 2020. It is further projected to be growing at a CAGR of 3.7% and worth USD xx billion by 2028. In the following years, the market is poised to grow significantly with the rising global population.

Market Dynamics

Market Growth Drivers Analysis

The North American Antifungal drugs market is expected to be driven by the proliferation of contagious diseases, the rising number of fungal infectious diseases such as miconazole and terbinafine. Also, the increased health concerns and expanding government and non-government support for antifungal disorders are expected to drive the market growth rate throughout the forecast period. The adoption of technological advancement in the production of various pharmaceuticals and delivering effective treatment techniques for various infectious diseases around the region is expected to fuel the growth of North America antifungal drugs market. The market is also likely to be aided by increased investment in research & development institutes. Increased cancer rates, a surge in hematopoietic stem cell transplantation, and other immune system-related factors are all driving the growth of the North American antifungal drugs market.

Market Restraints

The concerned associated long-term side effects with the usage of these drugs hamper the market growth in addition antifungal drug demand is also being slowed by variations in the rate of pharmaceutical manufacture. In addition, the scarcity of qualified personnel in the pharmaceutical manufacturing industries, which is the key restraint in the North America antifungal drugs market. However, the economy slows down, with the pandemic being the primary cause of improper government funds to cure these fungal viral infections. Furthermore, the government's stringent rules and regulations for approving new drugs are the major challenging factor.

COVID-19 impact on US Anti-Fungal Market

The COVID-19 pandemic is expected to have a significant impact on the market. As the import and export activities have been restricted due to the lockdown, it is expected to negatively impact the market studied due to shortage and irregular supply of raw materials and finished medical supplies and drugs. However, this might allow local manufacturers to increase their presence in the market. Supply disruption and medicine shortages of medical supplies have been observed in several countries due to the temporary lockdowns of manufacturing sites, export bans, increased demands for medicine for the treatment of COVID-19, and the stockpiling of medicines by individuals.

Competitive Landscape

Key Players

the key players operating in the antifungal drugs market, such as Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc.

The other players of the antifungals drugs market include Astellas Pharma, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Inc., Beckman Coulter, Inc. (a subsidiary of Danaher Corporation), Kramer Laboratories, Basilea Pharmaceutical Ltd., Valeant Pharmaceuticals International, Inc., and Tecan Group.

Products in Pipeline

In 2019, Mayne Pharma announced the launch of TOLSURA (SUBA-itraconazole) 65mg capsule in the United States.
Ibrexafungerp (MK-3118 and SCY-078; developed by Scynexis, Jersey City, NJ, USA) is a first-in-class oral glucan synthase inhibitor.

Notable Recent Deals

In June 2021, Cadila Pharmaceuticals launched a new triazole antifungal drug Posaconazole that is effective against a wide range of invasive fungal diseases. Additionally, the drug has been recommended as a second-line treatment for Mucormycosis.

In June 2021, Scynexis announced the approval of Brexafemme, bu the United States Food and Drug Administration for the treatment of vaginal yeast infections.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

Private plans typically include medical and pharmacy benefits. Drugs used with Durable Medical Equipment (DME) are often covered under the pharmacy benefit. Physician-administered drugs, regardless of formulation, are typically covered and paid under the medical benefit. FDA approval is typically a prerequisite for coverage, but private plans have a greater flexibility than public plans in defining the benefit category and placement of drugs on formularies, as well as adopting utilization controls.

To Know More About COVID-19 Impact On US Anti-Fungal Market @ https://www.prudentmarkets.com/sample-request/141792/

US Anti-Fungal Market Analysis Segmentation

By Drug Type:

Based on Drug type, the market is segmented into azoles, echinocandins, polyenes, and allylamines. Azoles are considered to be the leading segment owing to its fungicidal properties and increased revenue generation in 2019. Azoles are systemic antifungal drugs that include fluconazole, and others which are highly recommended for fungal infection treatment, thereby up scaling the market.

By Therapeutic Indications:

In terms of indication, the market is segmented into dermatophytosis, aspergillosis, candidiasis, and others. Dermatophytosis is a non-fatal superficial infection on skin. Dermatophytosis is anticipated to dominate the market owing to an increase in prevalence of dermatophytosis cases.

By Application:

In terms of Application, it is divided into powders, ointments, drugs, and pastes. Drugs are not only anticipated to remain the dominant segment in the near future but are also projected to grow at the fastest CAGR of 4.2%.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141792/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global US Anti-Fungal Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global US Anti-Fungal Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the US Anti-Fungal market
Chapter 2: Exclusive Summary - the basic information of the US Anti-Fungal Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the US Anti-Fungal
Chapter 4: Presenting the US Anti-Fungal Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the US Anti-Fungal market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141792/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the US Anti-Fungal Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.